Skip to content

Calcium-D supplementation effects in sugar control in gestational diabetes

Evaluation of Calcium-D supplementation effects in sugar control in patients with gestational diabetes

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100102002954N11
Enrollment
84
Registered
2018-09-04
Start date
2018-05-22
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes. Diabetes mellitus in pregnancy, unspecified

Interventions

administration of 500 mg of calcium carbonate per day plus 1000 units of vitamin D per day, together with routine gestational diabetes mellitus treatment during the study. Intervention 2: Control grou
only administration of routine gestational diabetes treatment during the study.

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: GDM test positive in 26-24 weeks of pregnancy Pregnant women without the previous diagnosis of glucose intolerance Satisfaction in rasarach

Exclusion criteria

Exclusion criteria: Previous diabetes history Premature rupture of the membrane Pausing suddenly of corion Pregnancy hypertension Eclampsia Chronic hypertension Hypothyroidism Need to start insulin therapy during the intervention Dissatisfaction in rasarach

Design outcomes

Primary

MeasureTime frame
Blood glucose measurement. Timepoint: At the beginning of the study and 3 months after starting Calcium-D intake. Method of measurement: Laboratory method of sugar measurement.;Measuring glycosylated hemoglobin. Timepoint: At the beginning of the study and 3 months after the start of Calcium-D intake. Method of measurement: Laboratory method for glycosylated hemoglobin mesurement.

Secondary

MeasureTime frame
Cratenin measurement. Timepoint: At the beginning of the study and 3 months after Calcium-D intake. Method of measurement: laboratory method of Cratenin measurement.;Urea measurement. Timepoint: At the beginning of the study and 3 months after Calcium-D intake. Method of measurement: laboratory method of urea measurement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Bagher Sohrabi

Shahroud University of Medical Sciences

mb.sohrabi@yahoo.com+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026